Artificial intelligence-based drug discovery company Chai Discovery on Tuesday revealed that it reached a $3.8 billion valuation after closing its latest funding round with $400 million in tow.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | AI Drug Discovery Biz Valued At $3.8B After Series C Round | 0 | 5 | 14-07-2026 |
| 2 | Chai Discovery Raises $400 Million Series C To Advance AI-Driven Molecular Design | 5 | 7 | 14-07-2026 |
| 3 | Suno Unveils $400 Million Series D, Tees Up the Release of Its ‘First Music Model Developed in Partnership With the Music Industry’ | 5 | 7 | 03-06-2026 |
| 4 | Insurance Tech Co. Hits $1.9B Valuation After Fundraise | 0 | 5 | 14-07-2026 |
| 5 | Legal AI startup Norm Ai hits $1.2 billion valuation after $120 million funding | 5 | 7 | 07-07-2026 |
| 6 | WSJ: бум компаний в сфере ИИ может обернуться новым "пузырем доткомов" | 0 | 0 | 10-03-2025 |
| 7 | Tencent та Alibaba планують інвестувати в DeepSeek: оцінка ШІ-стартапу перевищила млрд | 5 | 7 | 27-04-2026 |
| 8 | United Therapeutics Buys Thymmune For Up To $300M | 0 | 5 | 02-07-2026 |
| 9 | DeepSeek стал самым дорогим китайским AI-стартапом | 0 | 10 | 17-06-2026 |
| 10 | В Китае фармацевтическая компания оштрафована на $3,8 млн за незаконную торговлю активами | 0 | 0 | 27-05-2020 |